hers tirzepatide reviews on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Hers and Zepbound: Program Overview

Keeping the vial in the same spot in the refrigerator and checking it under the same light conditions each time makes comparison easier

Any persistent difficulty eating, unintended rapid weight loss, or severe gastrointestinal symptoms should prompt consultation with a healthcare provider, as dose adjustment or additional interventions may be necessary

[1] [3] Administered as a once-weekly subcutaneous injection, it works by mimicking the action of the naturally occurring hormone GLP-1, which helps regulate blood glucose levels by stimulating insulin secretion, suppressing glucagon release, and slowing gastric emptying

Virchows Arch B Cell Pathol 20: 217-228, 1976